Global Prostate Cancer Therapeutics Market Size study, By Therapy (Hormone Therapy, Targeted Therapy, Chemotherapy, and Biologic Therapy) and By Distribution Channel (Hospital Pharmacies, Online Sales, Retail Pharmacies, and Others), and Regional Forecasts 2020-2027

  • Product Code:
    RP-ID-10346660
  • Published Date:
    4 Jan 2021
  • Region:
    Global
  • Pages:
    201
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-14

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

Global Prostate Cancer Therapeutics Market is valued approximately at USD 9.9 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 7.68% over the forecast period 2020-2027. According to data released by the World Cancer Research Fund International, more than 1.1 million cases of prostate cancer have been registered in 2012, accounting for around 8 percent of the total tumor cases. Although the exact cause of prostate cancer is not known, the factors associated with it include overweight, obesity, and the history of any other tumor growth. And patients with cardiovascular disease are vulnerable to cancer metastases. As a result, the rising incidence rate of the above-mentioned conditions is driving market growth. The introduction of emerging technologies in screening and diagnostic tests is expected to drive development. The integration of multiparametric MRI (mp-MRI) will greatly enhance tumor detection and also validate the need for tissue biopsy. In addition, market players are investing in research to develop therapeutic drugs for the treatment of such tumors. For example, there is a strong pipeline of products such as Tc-99 m (Progenics), radium-223 dichloride (Xofigo, Bayer), ODM-201 (Orion and Bayer), which are in phase 3 studies and are expected to enter the market in the near future. In addition, due to the expiry of the patents of the major existing products, many generic products are expected to reach the market during the forecast period. As a result, these factors are expected to drive growth. In addition to screening and diagnostic testing, recognition of the availability of drugs to the public is also of the utmost importance to break down the social stigma associated with tumor therapy and to enable patients to be offered prompt care. Governments in developing countries are making efforts to undertake and introduce programs to raise awareness of screening tests, such as Prostate-specific antigen (PSA) blood tests and Digital Rectal Exam (DRE) for male patients over 50 years of age. Prostate Cancer Canada has been founded to promote research, care and prevention of prostate cancer. Such awareness campaigns are also being introduced in developing countries such as China, India and Brazil.
The regional analysis of global Prostate Cancer Therapeutics Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is expected to dominate the market share over the forecast period (2020-2027). Rising prevalence and high mortality rates of prostate cancer in the U.S. are the primary reasons for North America 's market supremacy. In addition, this region is experiencing a high level of investment in R&D to develop newer immunotherapy and targeted drug therapies to treat these tumors.
Major market player included in this report are:
Bayer AG
Johnson & Johnson
Ipsen Group
Amgen, Inc.
Endo Pharmaceuticals, Inc.
AbbVie, Inc.
Pfizer, Inc.
AstraZeneca
Sanofi
Sanpower Group
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Therapy:
Hormone Therapy
Targeted Therapy
Chemotherapy
Biologic Therapy
By Distribution Channel:
Hospital Pharmacies
Online Sales
Retail Pharmacies
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Prostate Cancer Therapeutics Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Prostate Cancer Therapeutics Market, by Region, 2018-2027 (USD Billion)
1.2.2. Prostate Cancer Therapeutics Market, by Therapy, 2018-2027 (USD Billion)
1.2.3. Prostate Cancer Therapeutics Market, by Distribution Channel, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Prostate Cancer Therapeutics Market Definition & Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Prostate Cancer Therapeutics Market Dynamics
3.1. Prostate Cancer Therapeutics Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Prostate Cancer Therapeutics Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Prostate Cancer Therapeutics Market, by Therapy
5.1. Market Snapshot
5.2. Global Prostate Cancer Therapeutics Market by Therapy, Performance - Potential Analysis
5.3. Global Prostate Cancer Therapeutics Market Estimates & Forecasts by Therapy, 2017-2027 (USD Billion)
5.4. Prostate Cancer Therapeutics Market, Sub Segment Analysis
5.4.1. Hormone Therapy
5.4.2. Targeted Therapy
5.4.3. Chemotherapy
5.4.4. Biologic Therapy
Chapter 6. Global Prostate Cancer Therapeutics Market, by Distribution Channel
6.1. Market Snapshot
6.2. Global Prostate Cancer Therapeutics Market by Distribution Channel, Performance - Potential Analysis
6.3. Global Prostate Cancer Therapeutics Market Estimates & Forecasts by Distribution Channel, 2017-2027 (USD Billion)
6.4. Prostate Cancer Therapeutics Market, Sub Segment Analysis
6.4.1. Hospital Pharmacies
6.4.2. Online Sales
6.4.3. Retail Pharmacies
6.4.4. Others
Chapter 7. Global Prostate Cancer Therapeutics Market, Regional Analysis
7.1. Prostate Cancer Therapeutics Market, Regional Market Snapshot
7.2. North America Prostate Cancer Therapeutics Market
7.2.1. U.S. Prostate Cancer Therapeutics Market
7.2.1.1. Therapy breakdown estimates & forecasts, 2017-2027
7.2.1.2. Distribution Channel breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Prostate Cancer Therapeutics Market
7.3. Europe Prostate Cancer Therapeutics Market Snapshot
7.3.1. U.K. Prostate Cancer Therapeutics Market
7.3.2. Germany Prostate Cancer Therapeutics Market
7.3.3. France Prostate Cancer Therapeutics Market
7.3.4. Spain Prostate Cancer Therapeutics Market
7.3.5. Italy Prostate Cancer Therapeutics Market
7.3.6. Rest of Europe Prostate Cancer Therapeutics Market
7.4. Asia-Pacific Prostate Cancer Therapeutics Market Snapshot
7.4.1. China Prostate Cancer Therapeutics Market
7.4.2. India Prostate Cancer Therapeutics Market
7.4.3. Japan Prostate Cancer Therapeutics Market
7.4.4. Australia Prostate Cancer Therapeutics Market
7.4.5. South Korea Prostate Cancer Therapeutics Market
7.4.6. Rest of Asia Pacific Prostate Cancer Therapeutics Market
7.5. Latin America Prostate Cancer Therapeutics Market Snapshot
7.5.1. Brazil Prostate Cancer Therapeutics Market
7.5.2. Mexico Prostate Cancer Therapeutics Market
7.6. Rest of The World Prostate Cancer Therapeutics Market

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Bayer AG
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Industry Summary
8.2.1.5. Recent Developments
8.2.2. Johnson & Johnson
8.2.3. Ipsen Group
8.2.4. Amgen, Inc.
8.2.5. Endo Pharmaceuticals, Inc.
8.2.6. AbbVie, Inc.
8.2.7. Pfizer, Inc.
8.2.8. AstraZeneca
8.2.9. Sanofi
8.2.10. Sanpower Group
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research AssumptionList of Tables
TABLE 1. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET, REPORT SCOPE
TABLE 2. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY REGION 2017-2027 (USD BILLION)
TABLE 3. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY THERAPY 2017-2027 (USD BILLION)
TABLE 4. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY DISTRIBUTION CHANNEL 2017-2027 (USD BILLION)
TABLE 5. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 6. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 7. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 8. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 9. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 10. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 11. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 12. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 13. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 14. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 15. U.S. PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 16. U.S. PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 17. U.S. PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 18. CANADA PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 19. CANADA PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 20. CANADA PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 21. UK PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 22. UK PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 23. UK PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 24. GERMANY PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 25. GERMANY PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 26. GERMANY PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 27. ROE PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 28. ROE PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 29. ROE PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 30. CHINA PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 31. CHINA PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 32. CHINA PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 33. INDIA PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 34. INDIA PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 35. INDIA PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 36. JAPAN PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 37. JAPAN PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 38. JAPAN PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 39. ROAPAC PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 40. ROAPAC PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 41. ROAPAC PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 42. BRAZIL PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 43. BRAZIL PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 44. BRAZIL PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 45. MEXICO PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 46. MEXICO PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 47. MEXICO PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 48. ROLA PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 49. ROLA PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 50. ROLA PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 51. ROW PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
TABLE 52. ROW PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 53. ROW PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
TABLE 54. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL PROSTATE CANCER THERAPEUTICS MARKET
TABLE 55. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL PROSTATE CANCER THERAPEUTICS MARKET
TABLE 56. YEARS CONSIDERED FOR THE STUDY
TABLE 57. EXCHANGE RATES CONSIDEREDList of Figures
FIG 1. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET, KEY TRENDS 2019
FIG 5. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET, GROWTH PROSPECTS 2020-2027
FIG 6. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET, PEST ANALYSIS
FIG 8. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 10. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 11. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 12. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 13. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
FIG 14. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET, REGIONAL SNAPSHOT 2017 & 2027
FIG 15. NORTH AMERICA PROSTATE CANCER THERAPEUTICS MARKET 2017 & 2027 (USD BILLION)
FIG 16. EUROPE PROSTATE CANCER THERAPEUTICS MARKET 2017 & 2027 (USD BILLION)
FIG 17. ASIA PACIFIC PROSTATE CANCER THERAPEUTICS MARKET 2017 & 2027 (USD BILLION)
FIG 18. LATIN AMERICA PROSTATE CANCER THERAPEUTICS MARKET 2017 & 2027 (USD BILLION)
FIG 19. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET, COMPANY MARKET SHARE ANALYSIS (2019)

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Bayer AG
Johnson & Johnson
Ipsen Group
Amgen, Inc.
Endo Pharmaceuticals, Inc.
AbbVie, Inc.
Pfizer, Inc.
AstraZeneca
Sanofi
Sanpower Group

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports